Jinen Song

721 citations
14 papers · 439 indexed · 1 hit paper · h-index 10
Topics
CAR-T cell therapy research (3 papers)Cancer Immunotherapy and Biomarkers (3 papers)Melanoma and MAPK Pathways (3 papers)

In The Last Decade

Jinen Song

14 papers receiving 436 citations

Hit Papers

Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of ci...2023202620242025202350100150200

Peers

Jinen Song
Comparison fields: 5 of 70
  • Oncology 222
  • Molecular Biology 159
  • Immunology 157
  • Cancer Research 92
  • Pulmonary and Respiratory Medicine 63
Replace Yongshuai Jiang with:
Yongshuai Jiang China
Ya-Chin Hou Taiwan
Samantha Lasser Germany
Shaima’a Hamarsheh Germany
Qiuhui Li China
Hiroko Kitahara Japan
Stefan Bissinger Germany
Takuro Yukawa Japan
Na Zhou China
М. Р. Патышева Russia
Jinen Song relative to Yongshuai Jiang China Yongshuai Jiang's profile →
Citations per field
00.5×1.5×
Yongshuai Jiang · 1×
Citations per year

Countries citing papers authored by Jinen Song

Since Specialization
Citations

This map shows the geographic impact of Jinen Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinen Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinen Song more than expected).

Fields of papers citing papers by Jinen Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinen Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinen Song. The network helps show where Jinen Song may publish in the future.

Co-authorship network of co-authors of Jinen Song

This figure shows the co-authorship network connecting the top 25 collaborators of Jinen Song. A scholar is included among the top collaborators of Jinen Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinen Song. Jinen Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 2
2
Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillancebreakdown →
217
3 4
4 11
5 16
6 47
7 10
8 19
9 5
10 23
11 31
12 33
13 19
14 2

About Jinen Song

Jinen Song is a scholar working on Oncology, Cancer Research and Immunology, having authored 14 papers that have together received 439 indexed citations. Recurring topics across this work include CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Melanoma and MAPK Pathways (3 papers). The work is most often cited by research in Oncology (222 citations), Immunology (157 citations) and Cancer Research (92 citations). Jinen Song has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Hubing Shi, Xuelei Ma, Xiaowei Liu, Yujie Zhao, Xi Wu, Jing Jing, Hu Zhang, Xinyu Guo, Hao Zhang and Xinyu Liu. Their work appears in journals such as Advanced Functional Materials, Cancer Cell and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026